Cancer Clinical Trials in Houston

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
H
Not yet recruiting
  • Cancer
  • +6 more
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
2021-10-14
Oct 14, 2021
T
Recruiting
  • Cancer
  • New Haven, Connecticut
  • +9 more
2021-10-11
Oct 11, 2021
I
Recruiting
  • Solid Tumor
  • +3 more
  • IMA201 Product
  • IMADetect®
  • Chicago, Illinois
  • +6 more
2021-10-01
Oct 1, 2021
S
Recruiting
  • Cancer
  • +3 more
    • Birmingham, Alabama
    • +39 more
    2021-09-28
    Sep 28, 2021
    M
    Recruiting
    • Solid Tumors
    • Cancer
    • MEDI1191
    • Durvalumab
    • Tucson, Arizona
    • +15 more
    2021-09-28
    Sep 28, 2021
    P
    Completed
    • Cancer
    • Alhambra, California
    • +37 more
    2021-09-21
    Sep 21, 2021
    M
    Not yet recruiting
    • Brain Metastases
    • +3 more
    • F18 Fluciclovine
    • Standard of Care
    • Houston, Texas
      M D Anderson Cancer Center
    2021-09-22
    Sep 22, 2021
    M
    Not yet recruiting
    • Pulmonary Hemorrhage
    • Cancer
    • tranexamic acid
    • Usual Care
    • Houston, Texas
      M D Anderson Cancer Center
    2021-09-20
    Sep 20, 2021
    M
    Active, not recruiting
    • Fatigue
    • Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    2021-09-15
    Sep 15, 2021
    M
    Active, not recruiting
    • Cancer
    • High-flow Oxygen
    • +3 more
    • Houston, Texas
      The University of Texas MD Anderson Cancer Center
    2021-08-24
    Aug 24, 2021
    I
    Recruiting
    • Refractory Cancer
    • +3 more
    • IMA203 Product
    • +2 more
    • New York, New York
    • +7 more
    2021-09-10
    Sep 10, 2021
    I
    Recruiting
    • Solid Tumor, Adult
    • +3 more
    • IMA202 Product
    • IMADetect®
    • New York, New York
    • +8 more
    2021-09-10
    Sep 10, 2021
    A
    Recruiting
    • Cancer
    • Non-small Cell Lung Cancer (NSCLC)
    • Cofetuzumab Pelidotin
    • Birmingham, Alabama
    • +26 more
    2021-09-01
    Sep 1, 2021
    I
    Active, not recruiting
    • Cancer
    • Solid Tumor
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    2021-08-18
    Aug 18, 2021
    S
    Recruiting
    • Cancer
    • SRK-181
    • anti-PD-(L)1 antibody therapy
    • Boston, Massachusetts
    • +5 more
    2021-08-04
    Aug 4, 2021
    I
    Recruiting
    • Central Nervous System Infections
    • +6 more
    • Device Group 1: Tactile Imaging (VerTouch)
    • Group 2: Control (palpation)
    • Providence, Rhode Island
    • +1 more
    2021-08-03
    Aug 3, 2021
    S
    Active, not recruiting
    • Cancer
      • Fontana, California
      • +57 more
      2021-07-08
      Jul 8, 2021
      A
      Recruiting
      • Advanced Solid Tumors
      • +2 more
      • New Haven, Connecticut
      • +18 more
      2021-05-25
      May 25, 2021